Mannheim
Germany
28
2022-01-20
The entities that hold a legal rights for patent applications filed by inventor EBERT Ulrich:
Ulrich EBERT from Mannheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF
#2 | 2018-04-05AMYLOID-BETA BINDING PROTEINS
#3 | 2018-03-08Monoclonal antibodies against amyloid beta protein and uses thereof
#4 | 2017-01-26Anti-Aβ globulomer 4D10 antibodies
#5 | 2017-01-05ANTIBODIES TO RECEPTOR OF ADVANCED GLYCATION END PRODUCTS (RAGE) AND USES THEREOF
#6 | 2016-11-10Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
#7 | 2016-06-09MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF
#8 | 2015-08-06Amyloid-beta binding proteins
#9 | 2015-06-25Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
#10 | 2015-03-19METHOD FOR THE TREATMENT OF AMYLOIDOSES
#11 | 2015-03-12MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF
#12 | 2014-08-14Amyloid-beta binding proteins
#13 | 2014-05-08Anti-Aβ globulomer 7C6 antibodies
#14 | 2013-10-31Abeta conformer selective anti-Abeta globulomer monoclonal antibodies
#15 | 2013-06-13Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
#16 | 2011-11-24Monoclonal antibodies against amyloid beta protein and uses thereof
#17 | 2011-10-20Amyloid-beta binding proteins
#18 | 2011-09-01Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
#19 | 2011-06-02Method for the treatment of amyloidoses
#20 | 2010-07-08Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereof
#21 | 2010-02-04Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
#22 | 2009-09-24Amyloid-beta globulomer antibodies
#23 | 2009-09-17Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
#24 | 2009-07-30Anti-Aβ globulomer 5F7 antibodies
#25 | 2009-07-09HUMANIZED ANTIBODIES TO AB (20-42) GLOBULOMER AND USES THEREOF
#26 | 2009-04-306-ARYLAMINO-5-CYANO-4-PYRIMIDINONES AS PDE9A INHIBITORS
#27 | 2009-02-05Aβ conformer selective anti-aβ globulomer monoclonal antibodies
#28 | 2007-05-106-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
285637 ⎘